SMi presents the 6th Annual Conference:
Date: 9th – 10th April 2018
Location: Copthorne Tara Hotel, London UK
SMi’s global panel of speakers will strengthen your knowledge in key topics such as high potent ingredients, ADC payloads, PK-PD technological advancements, warheads and site selectivity, immune-oncological combination therapies and fragment drug conjugates.
Hear from industry leading pharmaceutical companies and biotech’s including Pfizer, Genentech, Seattle Genetics, MedImmune, Janssen, Spirogen and more, who will explore key topics in; new and novel payloads, e.g. Antibody Targeted Amanitin Conjugates (ATACs), principles for maximising the drug delivery efficiency and therapeutic index and using fragment conjugates in order to develop a tailored therapy for solid tumours.
The ADC conference will discuss the best ways to approach obstacles faced during different stages of research. While such highly potent compounds can have significant benefits in the treatment of certain medical conditions, they present substantial challenges to the pharmaceutical industry. Most ADCs under clinical investigation contain cytotoxic agents that act by directly inducing DNA damage or exerting clastogenic effects.
Develop commercial potential in ADCs, as Justin Mason-Home, Director, HPAPI Project Services Limited, will be exploring the ADC component hazards, risk assessment, communication and management. Justin will also look into the health and safety project elements in designing and delivering HPAPI projects. – Day 1 | @16:00
For those looking to attend there are currently early-bird savings available.
Further information is available at: www.adcsummit.com/prmkt
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: email@example.com
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk